NCT04665414

Brief Summary

comparison of transvaginal ultrasound, transvaginal ultrasound elastography and MRI for the diagnosis of adenomyosis in patients receiving hysterectomy afterwards

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
103

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 29, 2017

Completed
3.2 years until next milestone

First Submitted

Initial submission to the registry

December 4, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 11, 2020

Completed
21 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2021

Completed
Last Updated

April 28, 2021

Status Verified

April 1, 2021

Enrollment Period

3.3 years

First QC Date

December 4, 2020

Last Update Submit

April 26, 2021

Conditions

Keywords

adenomyosisendometriosisMRIelastographyultrasoundhysterectomy

Outcome Measures

Primary Outcomes (8)

  • sensitivity MRI

    sensitivity MRI

    through study completion, an average of 1 year

  • specificity MRI

    specificity MRI

    through study completion, an average of 1 year

  • sensitivity transvaginal ultrasound

    sensitivity transvaginal ultrasound

    through study completion, an average of 1 year

  • specificity transvaginal ultrasound

    specificity transvaginal ultrasound

    through study completion, an average of 1 year

  • sensitivity transvaginal ultrasound elastography

    sensitivity transvaginal ultrasound elastography

    through study completion, an average of 1 year

  • specificity transvaginal ultrasound elastography

    specificity transvaginal ultrasound elastography

    through study completion, an average of 1 year

  • sensitivity intraoperative ENZIAN FA

    sensitivity intraoperative ENZIAN FA

    through study completion, an average of 1 year

  • specificity intraoperative ENZIAN FA

    specificity intraoperative ENZIAN FA

    through study completion, an average of 1 year

Secondary Outcomes (1)

  • sensitivity and specificity of single sonographic or MRI criteria or combinations thereof

    through study completion, an average of 1 year

Interventions

MRIDIAGNOSTIC_TEST

preoperative MRI

preoperative transvaginal ultrasound

preoperative transvaginal ultrasound elastography

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

all patients in accordance with eligibility criteria registered to receive hysterectomy because of a suspicion of adenomyosis according to the above criteria

You may qualify if:

  • dysmenorrhea
  • dyspareunia
  • non cyclic lower abdominal pain
  • hypermenorrhea
  • menometrorrhaghia
  • pain while compressing the Uterus during gyn exam
  • Patient wants to participate
  • Patient will receive hysterectomy

You may not qualify if:

  • Patient declines to participate
  • contraindications against MRI
  • contraindications against ultrasound
  • minor
  • cannot give informed consent
  • no hysterectomy planned

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Muenster

Münster, North Rhine-Westphalia, 48149, Germany

Location

MeSH Terms

Conditions

EndometriosisAdenomyosis

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesUterine Diseases

Study Officials

  • se D Schaefer, MD PhD

    University Hospital Muenster, Germany

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Gynecology

Study Record Dates

First Submitted

December 4, 2020

First Posted

December 11, 2020

Study Start

September 29, 2017

Primary Completion

January 1, 2021

Study Completion

January 31, 2021

Last Updated

April 28, 2021

Record last verified: 2021-04

Locations